SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-017718
Filing Date
2023-01-27
Accepted
2023-01-27 17:01:30
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d408286ds3.htm S-3 132210
2 EX-5.1 d408286dex51.htm EX-5.1 6917
3 EX-10.1 d408286dex101.htm EX-10.1 95729
4 EX-23.1 d408286dex231.htm EX-23.1 1636
5 EX-FILING FEES d408286dexfilingfees.htm EX-FILING FEES 30921
6 GRAPHIC g408286g0126235203121.jpg GRAPHIC 5905
7 GRAPHIC g408286g0126235203227.jpg GRAPHIC 2133
8 GRAPHIC g408286g03v00.jpg GRAPHIC 58328
  Complete submission text file 0001193125-23-017718.txt   355764
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Filer) CIK: 0001580063 (see all company filings)

IRS No.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-269446 | Film No.: 23564054
SIC: 2834 Pharmaceutical Preparations